Medicare Enrolled

Dr. Rafael Rivera-Rivera, MD

Pulmonary Disease · Wichita Falls, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1208 BROOK AVE, Wichita Falls, TX 76301
9403224480
In practice since 2006 (20 years)
NPI: 1669432209 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rivera-Rivera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rivera-Rivera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rivera-Rivera

Dr. Rafael Rivera-Rivera is a pulmonary disease specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rivera-Rivera performed 1,618 Medicare services across 1,033 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rivera-Rivera received a total of $15,342 from 44 pharmaceutical and/or device companies across 862 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rivera-Rivera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 29% volume in TX $15,342 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,618
Medicare services
Top 29% in TX for pulmonary disease
1,033
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~81 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min 396 $165 $530
Office visit, established patient (30-39 min) 381 $90 $240
Hospital follow-up visit, moderate complexity 204 $61 $163
Hospital follow-up visit, high complexity 133 $94 $238
Drug injection, under skin or into muscle 91 $11 $45
Office visit, established patient (20-29 min) 60 $67 $150
Test to determine lung volumes using sensors 54 $41 $110
Test to examine how well the lungs exchange gases 53 $43 $111
Test for exercise-induced lung stress 51 $25 $175
Initial hospital admission, moderate complexity 32 $100 $271
Test to measure expiratory airflow and volume 31 $21 $95
Initial hospital admission, high complexity 31 $129 $357
Test to measure expiratory airflow and volume changes before and after medication administration 28 $27 $128
Office visit, established patient, complex (40-54 min) 24 $128 $275
New patient office visit (45-59 min) 20 $126 $330
New patient office visit (30-44 min) 16 $71 $282
Office visit, established patient (10-19 min) 13 $22 $108
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,342
Total received (2018-2024)
Avg $2,192/year across 7 years
Top 14% in TX for pulmonary disease
44
Companies
862
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,342 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,061
2023
$2,676
2022
$2,404
2021
$1,857
2020
$1,403
2019
$2,275
2018
$1,666

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$3,170
AstraZeneca Pharmaceuticals LP
$2,426
Mylan Specialty L.P.
$1,678
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,102
Regeneron Healthcare Solutions, Inc.
$803
GENZYME CORPORATION
$705
Philips Electronics North America Corporation
$625
Actelion Pharmaceuticals US, Inc.
$498
Amgen Inc.
$415
Sunovion Pharmaceuticals Inc.
$402
United Therapeutics Corporation
$372
Genentech USA, Inc.
$367
Noah Medical Corporation
$303
Baxter Healthcare
$283
Grifols USA, LLC
$259
Novartis Pharmaceuticals Corporation
$242
ABIOMED
$200
Allergan Inc.
$165
Janssen Pharmaceuticals, Inc
$164
Merck Sharp & Dohme Corporation
$133
Takeda Pharmaceuticals U.S.A., Inc.
$123
Merck Sharp & Dohme LLC
$121
PFIZER INC.
$110
Insmed, Inc.
$92
JAZZ PHARMACEUTICALS INC.
$82
Mallinckrodt Hospital Products Inc.
$54
SANOFI-AVENTIS U.S. LLC
$53
Exeltis, USA Inc.
$44
Inspire Medical Systems, Inc.
$41
Electromed, Inc.
$40
Inari Medical, Inc.
$28
ANI Pharmaceuticals, Inc.
$26
Astellas Pharma US Inc
$23
Mallinckrodt Enterprises LLC
$23
Advanced Respiratory, Inc
$22
Tactile Systems Technology Inc
$21
Penumbra, Inc.
$19
Chiesi USA, Inc.
$19
CHIESI USA, INC.
$17
Teva Pharmaceuticals USA, Inc.
$17
Circassia Pharmaceuticals Inc
$16
Paratek Pharmaceuticals, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$12
Nabriva Therapeutics, plc
$12
Top 3 companies account for 47.4% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CLEVIPREX · CLEVIPREX 50MG/100ML · CRESEMBA · CUVITRU · DUPIXENT · Dymista · ELIQUIS · Esbriet · FASENRA · FLOWTRIEVER CATHETER · Flexitouch Plus · GALAXY · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · Impella · Indigo System · KEYTRUDA · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · S · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · WINREVAIR · XARELTO · XOLAIR · XYREM · Xenleta · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $948 per 100 Medicare services performed
Looking for a pulmonary disease specialist in Wichita Falls?
Compare pulmonary diseases in the Wichita Falls area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
4
Per 100K population
3.1
County median income
$62,168
Nearest hospital
UNITED REGIONAL HEALTH CARE SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rivera-Rivera is a clinical cardiology specialist, with above-average Medicare volume (top 29% in TX), with low-engagement industry engagement in the top 14% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rivera-Rivera experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Rivera-Rivera performed 396 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rivera-Rivera receive payments from pharmaceutical companies?
Yes. Dr. Rivera-Rivera received a total of $15,342 from 44 companies across 862 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rivera-Rivera's costs compare to other pulmonary diseases in Wichita Falls?
Dr. Rivera-Rivera's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rivera-Rivera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →